Davita Healthcare Partners Stock Analysis
DVA Stock | USD 165.63 2.33 1.39% |
DaVita HealthCare Partners is fairly valued with Real Value of 159.76 and Target Price of 113.0. The main objective of DaVita HealthCare stock analysis is to determine its intrinsic value, which is an estimate of what DaVita HealthCare Partners is worth, separate from its market price. There are two main types of DaVita HealthCare's stock analysis: fundamental analysis and technical analysis.
The DaVita HealthCare stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and DaVita HealthCare's ongoing operational relationships across important fundamental and technical indicators.
DaVita |
DaVita Stock Analysis Notes
About 49.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.25. DaVita HealthCare recorded earning per share (EPS) of 9.28. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 9th of September 2013. DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. Davita Healthcare operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 69000 people. To learn more about DaVita HealthCare Partners call Javier Rodriguez at 720 631 2100 or check out https://www.davita.com.DaVita HealthCare Quarterly Total Revenue |
|
DaVita HealthCare Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. DaVita HealthCare's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding DaVita HealthCare Partners or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
About 49.0% of the company shares are held by company insiders | |
Latest headline from MacroaxisInsider: Disposition of 8078 shares by Kathleen Waters of DaVita HealthCare at 108.93 subject to Rule 16b-3 |
DaVita HealthCare Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to DaVita HealthCare previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
13th of February 2024 Upcoming Quarterly Report | View | |
13th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
13th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
DaVita Largest EPS Surprises
Earnings surprises can significantly impact DaVita HealthCare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2002-02-26 | 2001-12-31 | 0.1 | 0.11 | 0.01 | 10 | ||
2001-11-05 | 2001-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2001-08-02 | 2001-06-30 | 0.08 | 0.09 | 0.01 | 12 |
DaVita HealthCare Environmental, Social, and Governance (ESG) Scores
DaVita HealthCare's ESG score is a quantitative measure that evaluates DaVita HealthCare's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of DaVita HealthCare's operations that may have significant financial implications and affect DaVita HealthCare's stock price as well as guide investors towards more socially responsible investments.
DaVita HealthCare Thematic Classifications
In addition to having DaVita HealthCare stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
ObamacareCompanies that count on Obamacare to take off | ||
HealthcareUSA Equities from Healthcare industry as classified by Fama & French | ||
Warren Buffett HoldingsEquities that Berkshire Hathaway invests in via either BRK-A or BRK-B common stocks |
DaVita Stock Institutional Investors
Shares | Allianz Asset Management Ag | 2024-06-30 | 538.7 K | Charles Schwab Investment Management Inc | 2024-09-30 | 501.6 K | Jpmorgan Chase & Co | 2024-06-30 | 470.1 K | Bank Of America Corp | 2024-06-30 | 452.6 K | Bank Of New York Mellon Corp | 2024-06-30 | 446.5 K | Citadel Advisors Llc | 2024-09-30 | 433.8 K | Legal & General Group Plc | 2024-06-30 | 432 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 408.7 K | Hrt Financial Llc | 2024-06-30 | 383.8 K | Berkshire Hathaway Inc | 2024-06-30 | 36.1 M | Vanguard Group Inc | 2024-09-30 | 5.4 M |
DaVita Market Capitalization
The company currently falls under 'Large-Cap' category with a total capitalization of 13.59 B.DaVita Profitablity
The company has Net Profit Margin of 0.07 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.16 %, which entails that for every 100 dollars of revenue, it generated $0.16 of operating income.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.07 | 0.07 | |
Return On Capital Employed | 0.11 | 0.15 | |
Return On Assets | 0.04 | 0.04 | |
Return On Equity | 0.65 | 0.69 |
Management Efficiency
DaVita HealthCare has Return on Asset of 0.0694 % which means that on every $100 spent on assets, it made $0.0694 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.4488 %, implying that it generated $0.4488 on every 100 dollars invested. DaVita HealthCare's management efficiency ratios could be used to measure how well DaVita HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, DaVita HealthCare's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Capital Employed is expected to grow to 0.15, whereas Return On Assets are forecasted to decline to 0.04. At present, DaVita HealthCare's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 762.2 M, whereas Total Assets are forecasted to decline to about 10.2 B.Last Reported | Projected for Next Year | ||
Book Value Per Share | 30.22 | 31.73 | |
Tangible Book Value Per Share | (50.36) | (47.84) | |
Enterprise Value Over EBITDA | 8.63 | 10.88 | |
Price Book Value Ratio | 9.01 | 9.46 | |
Enterprise Value Multiple | 8.63 | 10.88 | |
Price Fair Value | 9.01 | 9.46 | |
Enterprise Value | 19.4 B | 20.4 B |
The leadership approach at DaVita HealthCare's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Operating Margin 0.1628 | Profit Margin 0.0653 | Beta 0.887 | Return On Assets 0.0694 | Return On Equity 0.4488 |
Technical Drivers
As of the 29th of November, DaVita HealthCare shows the Downside Deviation of 2.4, mean deviation of 1.35, and Market Risk Adjusted Performance of 0.3138. DaVita HealthCare technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.DaVita HealthCare Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. DaVita HealthCare middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for DaVita HealthCare. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
DaVita HealthCare Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DaVita HealthCare insiders, such as employees or executives, is commonly permitted as long as it does not rely on DaVita HealthCare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DaVita HealthCare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
DaVita HealthCare Outstanding Bonds
DaVita HealthCare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. DaVita HealthCare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most DaVita bonds can be classified according to their maturity, which is the date when DaVita HealthCare Partners has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
DAVITA INC 375 Corp BondUS23918KAT51 | View | |
DaVita 4625 percent Corp BondUS23918KAS78 | View |
DaVita HealthCare Predictive Daily Indicators
DaVita HealthCare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of DaVita HealthCare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 0.0233 | |||
Daily Balance Of Power | (0.59) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 167.55 | |||
Day Typical Price | 166.91 | |||
Market Facilitation Index | 3.95 | |||
Price Action Indicator | (3.08) | |||
Period Momentum Indicator | (2.33) | |||
Relative Strength Index | 58.88 |
DaVita HealthCare Corporate Filings
F4 | 27th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 19th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 29th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 24th of September 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 17th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 13th of September 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 5th of September 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 29th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
DaVita HealthCare Forecast Models
DaVita HealthCare's time-series forecasting models are one of many DaVita HealthCare's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary DaVita HealthCare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About DaVita Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how DaVita HealthCare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling DaVita shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as DaVita HealthCare. By using and applying DaVita Stock analysis, traders can create a robust methodology for identifying DaVita entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.10 | 0.08 | |
Operating Profit Margin | 0.13 | 0.17 | |
Net Profit Margin | 0.06 | 0.05 | |
Gross Profit Margin | 0.31 | 0.34 |
Current DaVita Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. DaVita analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. DaVita analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
113.0 | Buy | 9 | Odds |
Most DaVita analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand DaVita stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of DaVita HealthCare, talking to its executives and customers, or listening to DaVita conference calls.
DaVita Stock Analysis Indicators
DaVita HealthCare Partners stock analysis indicators help investors evaluate how DaVita HealthCare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading DaVita HealthCare shares will generate the highest return on investment. By understating and applying DaVita HealthCare stock analysis, traders can identify DaVita HealthCare position entry and exit signals to maximize returns.
Begin Period Cash Flow | 339 M | |
Long Term Debt | 8.3 B | |
Common Stock Shares Outstanding | 93.2 M | |
Total Stockholder Equity | 1.1 B | |
Tax Provision | 220.1 M | |
Quarterly Earnings Growth Y O Y | -0.046 | |
Property Plant And Equipment Net | 5.6 B | |
Cash And Short Term Investments | 391.7 M | |
Cash | 380.1 M | |
Accounts Payable | 514.5 M | |
Net Debt | 10.7 B | |
50 Day M A | 158.4702 | |
Total Current Liabilities | 2.6 B | |
Other Operating Expenses | 10.5 B | |
Non Current Assets Total | 13.8 B | |
Forward Price Earnings | 14.4718 | |
Non Currrent Assets Other | 271.3 M | |
Stock Based Compensation | 112.4 M |
Complementary Tools for DaVita Stock analysis
When running DaVita HealthCare's price analysis, check to measure DaVita HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DaVita HealthCare is operating at the current time. Most of DaVita HealthCare's value examination focuses on studying past and present price action to predict the probability of DaVita HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DaVita HealthCare's price. Additionally, you may evaluate how the addition of DaVita HealthCare to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |